Eventide Asset Management’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
Eventide Asset Management's BLTE Position: Q3 2026 in Review
Eventide Asset Management held its Belite Bio (BLTE) position steady in Q3 2026 at 390,829 shares worth $66.4M. The position accounts for 0.93% of the portfolio, ranked #32.
Eventide Asset Management first reported a position in BLTE in Q3 2025 and has held it in 5 quarters since. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- Eventide Asset Management held 390,829 shares of Belite Bio worth $66.4M as of Q3 2026.
- Eventide Asset Management left its Belite Bio share count unchanged in Q3 2026.
- Belite Bio made up 0.93% of Eventide Asset Management's portfolio in Q3 2026, its #32 holding.
- Eventide Asset Management first reported a position in Belite Bio in Q3 2025 and has held it in 5 quarters since.
- 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on Eventide Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.